EMA consults on risk-based auditing of pharmacovigilance systems, communicating safety info
This article was originally published in Scrip
The European Medicines Agency is seeking feedback on two draft modules to be included in its good pharmacovigilance practice guideline (GVP). The latest modules pertain to pharmacovigilance audits and communication of safety information.
You may also be interested in...
Five new drugs have been recommended for EU approval at the latest meeting of European Medicines Agency’s drug evaluation committee.
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.